Pet Pharm Biotech Co., Ltd. (TPEX:7762)
Taiwan · Delayed Price · Currency is TWD 77.00
-0.70 (-0.90%)
At close: Oct 31, 2025
Pet Pharm Biotech Market Cap
Pet Pharm Biotech has a market cap or net worth of 3.94 billion as of October 31, 2025. Its market cap has increased by 155.35% in one year.
Market Cap
3.94B
Enterprise Value
3.55B
Revenue
159.02M
Ranking
n/a
PE Ratio
187.86
Stock Price
77.00
Market Cap Chart
Since July 26, 2024, Pet Pharm Biotech's market cap has increased from 1.39B to 3.94B, an increase of 183.22%. That is a compound annual growth rate of 127.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 3.94B | 138.16% |
| Dec 31, 2024 | 1.66B | 18.92% |
| Jul 26, 2024 | 1.39B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Taiwan Semiconductor Manufacturing Company | 38.90T |
| Hon Hai Precision Industry | 3.58T |
| Delta Electronics | 2.58T |
| MediaTek | 2.09T |
| Fubon Financial Holding | 1.28T |
| Quanta Computer | 1.16T |
| ASE Technology Holding | 1.08T |
| Chunghwa Telecom | 1.02T |